불임 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global infertility treatment market size is expected to reach USD 6.02 Billion in 2034 from USD 2.85 Billion in 2025, growing at a CAGR of 8.68 during 2026-2034.This market is experiencing rapid growth due to the increasing prevalence of infertility issues among both men and women worldwide. Factors such as delayed parenthood, lifestyle changes, stress, and medical conditions are contributing to rising infertility rates. Treatments including assisted reproductive technologies, medications, and surgical procedures are gaining widespread acceptance as awareness and accessibility improve across various regions.

The market is driven by advancements in reproductive technologies such as in vitro fertilization, improved success rates of treatments, and increasing healthcare expenditure. Growing awareness about fertility options and supportive government initiatives are encouraging more individuals to seek treatment. Additionally, the expansion of fertility clinics and the availability of advanced diagnostic tools are contributing to market growth.

In the future, the market is expected to witness continued innovation in reproductive medicine, including personalized treatment approaches and genetic screening technologies. Increasing social acceptance and reduced stigma around infertility will further boost demand. Expansion into emerging markets and improvements in affordability will play a crucial role in growth. The infertility treatment market is expected to grow significantly in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Equipment (Microscopes, Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices)
• Media & Consumables
• Accessories

By Procedure

• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgeries
• Other Infertility Treatment Procedures

By Patient Type

• Female Infertility Treatment
• Male Infertility Treatment

By End User

• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

COMPANIES PROFILED

• The Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Biomedx, IVFtech ApS, FUJIFILM Irvine Scientific, The Baker Company Inc., Kitazato Corporation, Rocket Medical plc, IHMedical A/S, Hamilton Thorne Ltd., ZEISS Group, MedGyn Products Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFERTILITY TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Equipment (Microscopes, Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Media & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFERTILITY TREATMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Assisted Reproductive Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Artificial Insemination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fertility Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Infertility Treatment Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFERTILITY TREATMENT MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Patient Type
• 6.2. Female Infertility Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Male Infertility Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFERTILITY TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Fertility Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals & Surgical Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cryobanks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFERTILITY TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Procedure
  • 8.2.3 By Patient Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Procedure
  • 8.3.3 By Patient Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Procedure
  • 8.4.3 By Patient Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Procedure
  • 8.5.3 By Patient Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Procedure
  • 8.6.3 By Patient Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL INFERTILITY TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 The Cooper Companies Inc
  • 10.2.2 Cook Group
  • 10.2.3 Vitrolife
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Esco Micro Pte. Ltd
  • 10.2.6 Genea Biomedx
  • 10.2.7 IVFtech ApS
  • 10.2.8 FUJIFILM Irvine Scientific
  • 10.2.9 The Baker Company Inc
  • 10.2.10 Kitazato Corporation
  • 10.2.11 Rocket Medical Plc
  • 10.2.12 IHMedical A/S
  • 10.2.13 Hamilton Thorne Ltd
  • 10.2.14 ZEISS Group
  • 10.2.15 MedGyn Products Inc